Leon Schurman
La Plata, B, Argentina
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Metformin reverts aortic calcifications and elastin loss induced by an experimental metabolic syndrome.
Journal: Endocrine connections
Published: December 30, 2024
Metformin treatment prevents experimental metabolic syndrome-induced femoral bone marrow adiposity in rats.
Journal: Revista peruana de medicina experimental y salud publica
Published: October 02, 2023
Argentine guidelines for the diagnosis, prevention and treatment of osteoporosis, 2015
Journal: Medicina
Published: February 01, 2017
Advanced glycation end products and strontium ranelate promote osteogenic differentiation of vascular smooth muscle cells in vitro: Preventive role of vitamin D.
Journal: Molecular and cellular endocrinology
Published: December 17, 2016
Effects of fructose-induced metabolic syndrome on rat skeletal cells and tissue, and their responses to metformin treatment.
Journal: Diabetes research and clinical practice
Published: August 30, 2016
Saxagliptin affects long-bone microarchitecture and decreases the osteogenic potential of bone marrow stromal cells.
Journal: European journal of pharmacology
Published: September 26, 2013
Insulin-deficient diabetes-induced bone microarchitecture alterations are associated with a decrease in the osteogenic potential of bone marrow progenitor cells: preventive effects of metformin.
Journal: Diabetes research and clinical practice
Published: March 14, 2013
Guidelines for the diagnosis, prevention and treatment of osteoporosis, 2012
Journal: Medicina
Published: January 22, 2013
Strontium ranelate prevents the deleterious action of advanced glycation endproducts on osteoblastic cells via calcium channel activation.
Journal: European journal of pharmacology
Published: October 05, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026